Olaparib combo improves PFS in metastatic prostate cancer :

Frontline olaparib plus abiraterone/prednisone combo improves survival in patients with metastatic castration-resistant prostate cancer.

Related Keywords

United Kingdom , Canada , Vancouver , British Columbia , Chicago , Illinois , United States , British , Maha Hussain , Kimn Chi , Roberth Lurie Comprehensive Cancer Center , Astrazeneca , Prostate Cancer Working Group , University Of British Columbia , Comprehensive Cancer Center , Both Dr Hussain , Prostate Carcinoma , Alignant Prostate Neoplasm , Prostate Cancer , Ancer Of The Prostate , Breast Cancer , Alignant Breast Neoplasm , Breast Carcinoma , Cancer , Alignant Neoplasia , Arcinoma , Alignant Neoplasm , Prostatic , Ovarian Cancer Malignant Neoplasm , Ovary Cancer , Genomics Genomic Medicine , Receptors , Parp Inhibitors , Parp Inhibition , Oly Adp Ribose Polymerase Inhibitor , Tumor ,